Skip to main content
Top
Published in: Acta Diabetologica 2/2013

01-04-2013 | Original Article

First-degree relatives of persons with type 1 diabetes: insulin resistance and enterovirus infection are associated with different patterns of islet cell autoimmunity

Authors: Ileana Cubas-Dueñas, Eduardo Cabrera-Rode, Luis Sarmiento, Gisela Molina, Magilé Fonseca, Celeste Arranz, Emma Domínguez, Pedro González, Manuel Vera, Oscar Díaz-Horta

Published in: Acta Diabetologica | Issue 2/2013

Login to get access

Abstract

Type 1 diabetes (T1D) results from the interaction of genetic and environmental factors. Previous studies indicate an association between detection of Enterovirus (EV) genome in blood and the clinical onset of T1D. Insulin resistance can also represent a risk factor for progression to clinically overt T1D. This study aimed at evaluating whether there is association between both EV infection and insulin resistance with islet autoantibodies in first-degree relatives of persons with type 1 diabetes. We collected sera from 94 first-degree relatives with (32) or without (64) islet cell antibodies (ICA) from the Cuban T1D prediction program. Blood glucose and insulin concentrations were determined. Antibodies to GAD65 and IA-2 were determined by radioimmunoassay. Insulin resistance was estimated by the homeostasis model assessment (HOMA-IR). EV-RNA was detected in serum using a highly sensitive reverse transcriptase-polymerase chain reaction method. The occurrence of EV-RNA was higher in ICA-positive relatives than in ICA-negative ones [15.6% (5/32) vs. 1.6% (1/62), P = 0.016]. GAD65 autoantibodies were more frequent in subjects with insulin resistance [34.5% (10/29) vs. 13.9% (9/65), P = 0.028] as defined by the HOMA-IR value. GAD65 autoantibodies also positively correlated with HOMA-IR (r.bis = 0.28, P < 0.01). IA-2 autoantibodies did correlate neither with EV-RNA nor with insulin resistance. There was no association between the presence of EV-RNA and insulin resistance. Our data suggest that enterovirus infection and insulin resistance are two independent events associated with ICA and GAD65 autoantibodies, respectively. These observations support the multifactorial nature of T1D.
Literature
1.
go back to reference Sarmiento-Pérez L, Cabrera-Rode E (eds) (2007) Enterovirus infections and type 1 diabetes mellitus. Nova Science Publishers, New York, pp 1–187 Sarmiento-Pérez L, Cabrera-Rode E (eds) (2007) Enterovirus infections and type 1 diabetes mellitus. Nova Science Publishers, New York, pp 1–187
2.
go back to reference American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62–S69CrossRef American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62–S69CrossRef
3.
go back to reference Couper JJ, Donaghue KC (2009) Diabetes stages in children and adolescents. Pediatric Diabetes 10(Suppl 12):13–16PubMedCrossRef Couper JJ, Donaghue KC (2009) Diabetes stages in children and adolescents. Pediatric Diabetes 10(Suppl 12):13–16PubMedCrossRef
4.
go back to reference Wenzlau JM, Moua O, Sarkar SA, Yu L, Rewers M, Eisenbarth GS et al (2008) S1C30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann NY Acad Sci 1150:256–259PubMedCrossRef Wenzlau JM, Moua O, Sarkar SA, Yu L, Rewers M, Eisenbarth GS et al (2008) S1C30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann NY Acad Sci 1150:256–259PubMedCrossRef
5.
go back to reference Richer M, Horwits M (2008) Viral infections in the pathogenesis of autoimmune diseases: focus on type 1 diabetes. Front Biosci 13:4241–4257PubMedCrossRef Richer M, Horwits M (2008) Viral infections in the pathogenesis of autoimmune diseases: focus on type 1 diabetes. Front Biosci 13:4241–4257PubMedCrossRef
6.
go back to reference Uriarte A, Cabrera Rode E, Ventura R, Vargas J (1990) Abnormalities of specific pancreatic immunity in children infected by Echo-4 virus. Rev Cubana Pediatria 3:359–362 Uriarte A, Cabrera Rode E, Ventura R, Vargas J (1990) Abnormalities of specific pancreatic immunity in children infected by Echo-4 virus. Rev Cubana Pediatria 3:359–362
7.
go back to reference Uriarte A, Molina G, Cabrera Rode E, Ventura R, Vargas J, Vera M (1991) Prospective study in children with high risk of type 1 diabetes after infection by echo 4 virus (1986–1989). Rev Cubana Endocrinol 2:34–43 Uriarte A, Molina G, Cabrera Rode E, Ventura R, Vargas J, Vera M (1991) Prospective study in children with high risk of type 1 diabetes after infection by echo 4 virus (1986–1989). Rev Cubana Endocrinol 2:34–43
8.
go back to reference Díaz Horta O, Bello M, Cabrera Rode E, Suárez J, Mas P, García I et al (2001) Echovirus 4 and type 1 diabetes mellitus. Autoimmunity 34:275–281PubMedCrossRef Díaz Horta O, Bello M, Cabrera Rode E, Suárez J, Mas P, García I et al (2001) Echovirus 4 and type 1 diabetes mellitus. Autoimmunity 34:275–281PubMedCrossRef
9.
go back to reference Cabrera-Rode E, Sarmiento L, Tiberti C, Molina G, Barrios J, Hernandez D et al (2003) Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia 46:1348–1353PubMedCrossRef Cabrera-Rode E, Sarmiento L, Tiberti C, Molina G, Barrios J, Hernandez D et al (2003) Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia 46:1348–1353PubMedCrossRef
10.
go back to reference Cabrera-Rode E, Sarmiento L, Molina G, Perez C, Arranz C, Galvan JA et al (2005) Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: a case report. J Med Virol 76:373–377PubMedCrossRef Cabrera-Rode E, Sarmiento L, Molina G, Perez C, Arranz C, Galvan JA et al (2005) Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: a case report. J Med Virol 76:373–377PubMedCrossRef
11.
go back to reference Sarmiento L, Cabrera-Rode E, Lekuleni L, Cuba I, Molina G, Fonseca M et al (2007) Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes. Autoimmunity 40:540–545PubMedCrossRef Sarmiento L, Cabrera-Rode E, Lekuleni L, Cuba I, Molina G, Fonseca M et al (2007) Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes. Autoimmunity 40:540–545PubMedCrossRef
12.
go back to reference Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661–1667PubMedCrossRef Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661–1667PubMedCrossRef
13.
go back to reference Bingley PJ, Mahon JL, Gale EA (2008) Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 31:146–150PubMedCrossRef Bingley PJ, Mahon JL, Gale EA (2008) Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 31:146–150PubMedCrossRef
14.
go back to reference Cabrera-Rode E, Marichal S, Parlá J, Arranz C, González R, Pérez C et al (2010) Frequency and characteristics of metabolic syndrome and insulin resistance in the first-degree relatives of persons with type 1 diabetes. Endocrinol Nutr 57:311–321PubMedCrossRef Cabrera-Rode E, Marichal S, Parlá J, Arranz C, González R, Pérez C et al (2010) Frequency and characteristics of metabolic syndrome and insulin resistance in the first-degree relatives of persons with type 1 diabetes. Endocrinol Nutr 57:311–321PubMedCrossRef
15.
go back to reference Cabrera-Rode E, Molina G, Arranz C, Vera M, Gonzalez P, Suarez R et al (2006) Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes. Autoimmunity 39:333–340PubMedCrossRef Cabrera-Rode E, Molina G, Arranz C, Vera M, Gonzalez P, Suarez R et al (2006) Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes. Autoimmunity 39:333–340PubMedCrossRef
16.
go back to reference Pilcher C, Elliott RB (1984) Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics. Lancet 1:1352PubMedCrossRef Pilcher C, Elliott RB (1984) Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics. Lancet 1:1352PubMedCrossRef
17.
go back to reference Schmidli RS, Colman PG, Bonifacio E (1995) Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb workshop. Diabetes 44:636–640PubMedCrossRef Schmidli RS, Colman PG, Bonifacio E (1995) Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb workshop. Diabetes 44:636–640PubMedCrossRef
18.
go back to reference Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E (1995) Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40 k autoantigen and a target of islet-cell antibodies. J Immunol 155:5419–5426PubMed Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E (1995) Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40 k autoantigen and a target of islet-cell antibodies. J Immunol 155:5419–5426PubMed
19.
go back to reference Halonen P, Rocha E, Hierholzen J (1995) Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization. J Clin Microbiol 33:648–653PubMed Halonen P, Rocha E, Hierholzen J (1995) Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization. J Clin Microbiol 33:648–653PubMed
20.
go back to reference Yang CF, De L, Yang SJ, Ruiz Gomez J, Cruz JR, Holloway BP et al (1992) Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res 24:277–296PubMedCrossRef Yang CF, De L, Yang SJ, Ruiz Gomez J, Cruz JR, Holloway BP et al (1992) Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res 24:277–296PubMedCrossRef
21.
go back to reference Kilpatrick DR, Nottay B, Yang CF, Yang SJ, Da Silva E, Penaranda S et al (1998) Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 36:352–357PubMed Kilpatrick DR, Nottay B, Yang CF, Yang SJ, Da Silva E, Penaranda S et al (1998) Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 36:352–357PubMed
22.
go back to reference Sarmiento L, Avalos I, Ramos Y, Mas P, Bello M, Palomera R (2000) Rapid detection of enterovirus by direct method of polymerase chain reaction. Rev Cubana Med Trop 52:15–20 Sarmiento L, Avalos I, Ramos Y, Mas P, Bello M, Palomera R (2000) Rapid detection of enterovirus by direct method of polymerase chain reaction. Rev Cubana Med Trop 52:15–20
23.
go back to reference Trinder P (1969) Determination of glucose oxidase with one alternative oxygen acceptor. Ann Clin Biochem 6:24–27 Trinder P (1969) Determination of glucose oxidase with one alternative oxygen acceptor. Ann Clin Biochem 6:24–27
24.
go back to reference Arranz Calzado C, González Suárez R (1988) Utilización de un método rápido para la separación de la hormona libre y unida en el radioinmunoensayo de insulina. Rev. Cubana Invest Biomed 7:150–156 Arranz Calzado C, González Suárez R (1988) Utilización de un método rápido para la separación de la hormona libre y unida en el radioinmunoensayo de insulina. Rev. Cubana Invest Biomed 7:150–156
25.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 28:412–419PubMedCrossRef
26.
go back to reference Arranz C, González RM, Álvarez A, Rodríguez B, Reyes A (2010) Reference criteria for insulin secretion indicators and of the lipid parameters in a hospital mixed population. Rev Cubana Endocrinol 21:1–12 Arranz C, González RM, Álvarez A, Rodríguez B, Reyes A (2010) Reference criteria for insulin secretion indicators and of the lipid parameters in a hospital mixed population. Rev Cubana Endocrinol 21:1–12
27.
go back to reference Chen PY, Popovich PM (2002) Correlation: parametric and nonparametric measures. Sage Publications, Thousand Oaks, CA Chen PY, Popovich PM (2002) Correlation: parametric and nonparametric measures. Sage Publications, Thousand Oaks, CA
28.
go back to reference Salminen KK, Vuorinen T, Oikarinen S, Helminen M, Simell S, Knip M et al (2004) Isolation of enterovirus strains from children with preclinical type 1 diabetes. Diabet Med 21:156–164PubMedCrossRef Salminen KK, Vuorinen T, Oikarinen S, Helminen M, Simell S, Knip M et al (2004) Isolation of enterovirus strains from children with preclinical type 1 diabetes. Diabet Med 21:156–164PubMedCrossRef
29.
go back to reference Coutant R, Carel JC, Lebon P, Bougneres PF, Palmer P, Cantero-Aguilar L (2002) Detection of enterovirus RNA sequences in serum samples from autoantibody-positive subjects at risk for diabetes. Diabet Med 19:968–969PubMedCrossRef Coutant R, Carel JC, Lebon P, Bougneres PF, Palmer P, Cantero-Aguilar L (2002) Detection of enterovirus RNA sequences in serum samples from autoantibody-positive subjects at risk for diabetes. Diabet Med 19:968–969PubMedCrossRef
30.
go back to reference Moya-Suri V, Schlosser M, Zimmermann K, Rjasanowski I, Gurtler L, Mentel R (2005) Enterovirus RNA sequences in sera of school children in the general population and their association with type 1-diabetes-associated autoantibodies. J Med Microbiol 54:879–883PubMedCrossRef Moya-Suri V, Schlosser M, Zimmermann K, Rjasanowski I, Gurtler L, Mentel R (2005) Enterovirus RNA sequences in sera of school children in the general population and their association with type 1-diabetes-associated autoantibodies. J Med Microbiol 54:879–883PubMedCrossRef
31.
go back to reference Lönnrot M, Salminen K, Knip M, Savola K, Kulmala P, Leinikki P et al (2000) Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 61:214–220PubMedCrossRef Lönnrot M, Salminen K, Knip M, Savola K, Kulmala P, Leinikki P et al (2000) Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 61:214–220PubMedCrossRef
32.
go back to reference Sadeharju K, Hamalainen AM, Knip M, Lonnrot M, Koskela P, Virtanen SM et al (2003) Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial. Clin Exp Immunol 132:271–277PubMedCrossRef Sadeharju K, Hamalainen AM, Knip M, Lonnrot M, Koskela P, Virtanen SM et al (2003) Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial. Clin Exp Immunol 132:271–277PubMedCrossRef
33.
go back to reference Isermann B, Ritzel R, Zorn M, Schilling T, Nawroth PP (2007) Autoantibodies in diabetes mellitus: current utility and perspectives. Exp Clin Endocrinol Diabetes 115:483–490PubMedCrossRef Isermann B, Ritzel R, Zorn M, Schilling T, Nawroth PP (2007) Autoantibodies in diabetes mellitus: current utility and perspectives. Exp Clin Endocrinol Diabetes 115:483–490PubMedCrossRef
34.
go back to reference Hela J, Sauter P, Sane F, Goffard A, Gharbi J, Hober D (2010) Enterovirus and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol 20:265–280CrossRef Hela J, Sauter P, Sane F, Goffard A, Gharbi J, Hober D (2010) Enterovirus and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol 20:265–280CrossRef
35.
go back to reference Pallansch M, Raymond P (2001) Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Knipe D, Howlen P, Griffin D (eds) Fields virology, 3rd edn. Lippincott Raven Publisher, Philadelphia, pp 123–775 Pallansch M, Raymond P (2001) Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Knipe D, Howlen P, Griffin D (eds) Fields virology, 3rd edn. Lippincott Raven Publisher, Philadelphia, pp 123–775
36.
go back to reference Filippi CM, von Herrath MG (2000) Viral trigger for type 1 diabetes: pros and cons. Diabetes 57:2863–2871CrossRef Filippi CM, von Herrath MG (2000) Viral trigger for type 1 diabetes: pros and cons. Diabetes 57:2863–2871CrossRef
37.
go back to reference Björk E, Kämpe O, Karlsson FA, Pipeleers DG, Anderson A, Hellerström C et al (1992) Glucose regulation of the autoantigen GAD65 in human pancreatic islet. J Clin Endocrinol Metab 75:1574–1576PubMedCrossRef Björk E, Kämpe O, Karlsson FA, Pipeleers DG, Anderson A, Hellerström C et al (1992) Glucose regulation of the autoantigen GAD65 in human pancreatic islet. J Clin Endocrinol Metab 75:1574–1576PubMedCrossRef
38.
go back to reference Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJK, Bingley PJ et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibodies characteristics. Diabetes 53:384–392PubMedCrossRef Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJK, Bingley PJ et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibodies characteristics. Diabetes 53:384–392PubMedCrossRef
39.
go back to reference Bruining GJ (2000) Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 356:655–656PubMedCrossRef Bruining GJ (2000) Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 356:655–656PubMedCrossRef
Metadata
Title
First-degree relatives of persons with type 1 diabetes: insulin resistance and enterovirus infection are associated with different patterns of islet cell autoimmunity
Authors
Ileana Cubas-Dueñas
Eduardo Cabrera-Rode
Luis Sarmiento
Gisela Molina
Magilé Fonseca
Celeste Arranz
Emma Domínguez
Pedro González
Manuel Vera
Oscar Díaz-Horta
Publication date
01-04-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0297-6

Other articles of this Issue 2/2013

Acta Diabetologica 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.